ARCHIVE

• New Adverse Reactions to Remicade, Iressa Reported: Safety Info.
  June 16, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  June 16, 2003

• Restructuring Programs Showing Visible Results:Mr Eiki of Bayer Yakuhin
  June 16, 2003

• MOF Presents "viewpoints for Healthcare Reform"
  June 16, 2003

• Kyorin to Revise Midterm Plan due to Sluggish Gatiflo Sales
  June 16, 2003

• REGULATORY NEWS IN BRIEF
  June 16, 2003

• Atol: Consolidated Sales, Profits Declined in FY2002
  June 9, 2003

• BUSUNESS NEWS IN BIEF
  June 9, 2003

• CORPORATE ROUNDUP NEWS IN BRIEF
  June 9, 2003

• Eisai Seeks Add'l Indication of Acute Pulmonary Embolism for Cleactor
  June 9, 2003

• ON THE MOVE
  June 9, 2003

• Nippon Shinyaku Licenses Acamprosate for Alcohol Dependence from Merck Sante
  June 9, 2003

• Add'l Indication of GIST Recommended for Novartis' Glivec
  June 9, 2003

• Suzuken, Astis Agree on Comprehensive Business Tie-up
  June 9, 2003

• 3 Healthcare-related Reform Proposals to Be Given Top Priority: Council's Recommendation
  June 9, 2003

• WEBSITE NEWS
  June 9, 2003

• FDA to Respond Soon to Talks on GMP/GCP Mutual Recognition
  June 9, 2003

• 27 Leading Drug Makers Post 2.2% Rise in Sales, 3.4% Drop in Net Profits
  June 9, 2003

• REGULATORY NEWS IN BRIEF
  June 9, 2003

• Taisho: Profits Down Despite Growth in Sales
  June 9, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 593
• 594
• 595
• 596
• 597
• 598
• 599
• 600
• 601
• …
• Next ›
• 最終 »